ASAPHARM: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ASAPHARM
Largest movements
- Financial fixed assets +€592,936
up €592,936 (+65.2%), from €910,000 to €1.5m
- Cash -€59,175
down €59,175 (-89.8%), from €65,868 to €6,694
mainly Investment in fixed assets (net) (-€611,256) and Contributions, distributions and other (-€231,910)
- Debts after one year +€311,482
up €311,482 (+36.6%), from €849,913 to €1.2m
- Other debts +€280,177
up €280,177 (+281.5%), from €99,515 to €379,692
- Profit (loss) carried forward -€92,233
down €92,233 (-39.8%), from €231,910 to €139,678
- Current portion of long-term debt +€46,288
up €46,288 (+51.4%), from €90,119 to €136,408
- Gross operating margin +€41,841
up €41,841 (+75.7%), from €55,265 to €97,106
- Financial charges +€11,388
up €11,388 (+80.9%), from €14,084 to €25,472
- Taxes +€10,194
up €10,194 (+132.3%), from €7,705 to €17,898
- Depreciation +€2,642
up €2,642 (+29.8%), from €8,858 to €11,500
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,302,808 | €1,860,860 | +€558,052 | +42.8% |
| Fixed assets | 21/28 | €1,234,548 | €1,834,303 | +€599,755 | +48.6% |
| Tangible fixed assets | 22/27 | €324,548 | €331,368 | +€6,820 | +2.1% |
| Land and buildings | 22 | €324,548 | €316,064 | -€8,484 | -2.6% |
| Furniture and vehicles | 24 | €0 | €15,304 | +€15,304 | |
| Financial fixed assets | 28 | €910,000 | €1,502,936 | +€592,936 | +65.2% |
| Current assets | 29/58 | €68,260 | €26,557 | -€41,703 | -61.1% |
| Amounts receivable within one year | 40/41 | €686 | €17,903 | +€17,218 | +2510.1% |
| Trade receivables | 40 | €372 | €17,878 | +€17,506 | +4706.7% |
| Other amounts receivable | 41 | €314 | €25 | -€289 | -92.0% |
| Cash at bank and in hand | 54/58 | €65,868 | €6,694 | -€59,175 | -89.8% |
| Deferred charges and accrued income | 490/1 | €1,706 | €1,960 | +€254 | +14.9% |
| Total equity and liabilities | 10/49 | €1,302,808 | €1,860,860 | +€558,052 | +42.8% |
| Equity | 10/15 | €252,370 | €160,138 | -€92,233 | -36.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €231,910 | €139,678 | -€92,233 | -39.8% |
| Amounts payable | 17/49 | €1,050,437 | €1,700,722 | +€650,285 | +61.9% |
| Amounts payable after more than one year | 17 | €849,913 | €1,161,395 | +€311,482 | +36.6% |
| Financial debts | 170/4 | €849,913 | €1,161,395 | +€311,482 | +36.6% |
| Amounts payable within one year | 42/48 | €196,681 | €534,729 | +€338,049 | +171.9% |
| Current portion of amounts payable after more than one year | 42 | €90,119 | €136,408 | +€46,288 | +51.4% |
| Trade debts | 44 | €420 | €5,427 | +€5,008 | +1192.9% |
| Suppliers | 440/4 | €420 | €5,427 | +€5,008 | +1192.9% |
| Taxes, remuneration and social security | 45 | €6,626 | €13,202 | +€6,576 | +99.2% |
| Taxes | 450/3 | €6,626 | €13,202 | +€6,576 | +99.2% |
| Other amounts payable | 47/48 | €99,515 | €379,692 | +€280,177 | +281.5% |
| Accrued charges and deferred income | 492/3 | €3,844 | €4,598 | +€755 | +19.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,858 | €11,500 | +€2,642 | +29.8% |
| Other operating charges | 640/8 | €2,573 | €2,557 | -€16 | -0.6% |
| Gross operating margin | 9900 | €55,265 | €97,106 | +€41,841 | +75.7% |
| Operating profit (loss) | 9901 | €43,834 | €83,048 | +€39,214 | +89.5% |
| Financial income | 75/76B | €100,000 | €100,000 | +€0 | 0.0% |
| Recurring financial income | 75 | €100,000 | €100,000 | +€0 | 0.0% |
| Financial charges | 65/66B | €14,084 | €25,472 | +€11,388 | +80.9% |
| Recurring financial charges | 65 | €14,084 | €25,472 | +€11,388 | +80.9% |
| Profit (loss) for the period before taxes | 9903 | €129,750 | €157,576 | +€27,827 | +21.4% |
| Income taxes | 67/77 | €7,705 | €17,898 | +€10,194 | +132.3% |
| Profit (loss) for the period | 9904 | €122,045 | €139,678 | +€17,633 | +14.4% |
| Profit (loss) for the period to be appropriated | 9905 | €122,045 | €139,678 | +€17,633 | +14.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.